Want to see HK:2315 full AI Analyst Report?

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (2315) Revenue

1 Followers

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H Revenue

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H had a revenue of 942.43M in the quarter ending Jun 30, 2026, with 24.36%. This bring the company's revenue in the last twelve months to 1.70B, Decreased 23.31%. In the fiscal year ending Dec 31, 2025, Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H had annual revenue of 1.38B with 40.63% growth.

Revenue (ttm)

1.70B

Revenue Growth

48.04%

P/S Ratio

22.30

Revenue/Employee

HK$955,515

Employees

1,443

Market Cap

HK$30.75B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	1.38B	398.35M	+40.63%
Dec 31, 2024	980.45M	263.54M	+36.76%
Dec 31, 2023	716.91M	183.03M	+34.28%
Dec 31, 2022	533.88M	179.33M	+50.58%
Dec 31, 2021	354.56M	101.01M	+39.84%
Dec 31, 2020	253.54M	―	―